Biotechnology

Gilead to pay $12 Billion for Kite Pharma

Samsung Bioepis and Takeda in Biologics Pact

Monsanto Licenses ToolGen’s CRISPR Technology

J&J Expects Actelion Deal to Close This Week

Bicycle Gains Funds for Cancer Drug Trials

UK Leads European Biotech Funding

Biogen Licenses Remedy’s Stroke Drug

South Africa Conditionally Approves Bayer-Monsanto

Topics • Strategy

China’s Investors Advance

Trump Chooses Gottlieb to Head FDA

Biotech Chiefs Lambaste Trump’s Travel Ban

J&J Clinches Actelion for $30 Billion

Silence Buys Into Arrowhead Pharmaceuticals

J&J and Actelion Said Talking to Swiss Regulators

Amyris and Nikkol in Cosmetic Ingredients Pact

Johnson & Johnson Quits Actelion Bid

AstraZeneca and Bicycle Therapeutics in Peptides Pact

Evonik Buys Metabolic’s Methionine Portfolio

Topics • Technology

Chemistry Works – at Every Level

Merck KGaA Expands Spanish Biotech Site

GE to Establish new Biotech Campus in Ireland

Trends in Chemical & Pharmaceutical Research

Bayer, Monsanto Sidestep Merger Concerns

Topics • Technology

Diagnosis: Innovation Insufficiency – Treatment: Combination Therapy

Topics • Technology

The Possibilities Of Peptides

Metabolix Sells Biopolymer Assets to CJ CheilJedang

Philippe Saudan Chief Development Officer at Kuros

Evonik to Acquire Transferra Nanosciences

Waking up to Brexit’s Bitter Aftertaste

Shire to Expand Biotech in Ireland

AstraZeneca Seen as Contender for Medivation

Evonik Buys Alkion Biopharma

Pioneer and Origin Agritech in Seeds Deal

Topics • Technology

Staying Ahead In Outsourcing

Metabolix and CheilJedang in PHA Deal

276 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Virtual Event

Outsourced Biomanufacturing

Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Federchimica

Olon S.p.A.

Bio4Business

Kaye Scholer

Dechema e.V.

GETEC Group

Numaferm GmbH

Dottikon Exclusive Synthesis AG

EvaluatePharma

CzechInvest

Berlin Partner für Wirtschaft und Technologie GmbH

PhytoAR Biotechnologie GmbH

AbbVie Inc.

Germany Trade & Invest

Farmindustria

Henkel AG & Co. KGaA

Beckman Coulter, Inc.

Managm. Consult. Chemicals

European Circular Bioeconomy Fund (ECBF)

International Sustainable Chemistry Collaborative Centre ISC3

Bio Consortia

WuXi AppTec

Evonik Industries AG

Jennewein Biotechnologie GmbH

AstraZeneca

Hamilton Bonaduz AG

ACIB Austrian Centre of Industrial Biotechnology

Millipore Corporation

Thomson Reuters

Arthur D. Little

Miebach Consulting GmbH

SK Pharmteco

Primogene GmbH

Groupe Novasep

Rentschler Biopharma SE

Novozymes Biopharma UK Ltd.

Tufts University

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences